Atticus Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-362
Closed -$8.78K 497
2025
Q2
$8.78K Buy
362
+4
+1% +$93 ﹤0.01% 488
2025
Q1
$9.07K Sell
358
-100
-22% -$2.62K ﹤0.01% 387
2024
Q4
$12.2K Buy
458
+3
+0.7% +$81 ﹤0.01% 376
2024
Q3
$13.2K Buy
455
+4
+0.9% +$117 ﹤0.01% 370
2024
Q2
$12.6K Sell
451
-893
-66% -$24.6K ﹤0.01% 358
2024
Q1
$37.3K Sell
1,344
-1,646
-55% -$45.7K 0.01% 272
2023
Q4
$86.1K Sell
2,990
-947
-24% -$28.6K 0.03% 185
2023
Q3
$131K Sell
3,937
-2,233
-36% -$79K 0.05% 154
2023
Q2
$226K Sell
6,170
-525
-8% -$20.4K 0.08% 121
2023
Q1
$273K Sell
6,695
-2,037
-23% -$88K 0.1% 109
2022
Q4
$447K Buy
8,732
+764
+10% +$36.6K 0.18% 78
2022
Q3
$418K Hold
7,968
0.2% 69
2022
Q2
$418K Buy
7,968
+2,292
+40% +$117K 0.17% 83
2022
Q1
$294K Buy
5,676
+2,202
+63% +$114K 0.11% 117
2021
Q4
$205K Buy
3,474
+1,301
+60% +$64.5K 0.08% 120
2021
Q3
$93K Sell
2,173
-2,303
-51% -$102K 0.04% 177
2021
Q2
$175K Buy
4,476
+11
+0.2% +$428 0.08% 122
2021
Q1
$162K Buy
4,465
+43
+1% +$1.53K 0.08% 120
2020
Q4
$163K Sell
4,422
-227
-5% -$8.33K 0.08% 117
2020
Q3
$162K Buy
4,649
+1
+0% +$35 0.1% 99
2020
Q2
$144K Buy
4,648
+18
+0.4% +$612 0.1% 106
2020
Q1
$143K Buy
4,630
+38
+0.8% +$1.29K 0.12% 94
2019
Q4
$171K Buy
+4,592
New +$164K 0.11% 94

Other funds holding PFE

Atticus Wealth Management's PFE Position: Q3 2025 in Review

Atticus Wealth Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 362 shares — an estimated $8.78K sold.

Atticus Wealth Management first reported a position in PFE in Q4 2019 and held it in 23 quarters. The position peaked at $447K in Q4 2022. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Atticus Wealth Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 362 Pfizer shares in Q3 2025, an estimated $8.78K.
  • Atticus Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 23 quarters.
  • Atticus Wealth Management's Pfizer position peaked at $447K in Q4 2022.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.